Phenylketonuria (PKU) Global Market Report 2025

Description

Phenylketonuria (PKU) is a rare inherited metabolic disorder in which the body is unable to break down the amino acid phenylalanine (Phe), which is present in many protein-containing foods. This condition results from a deficiency or malfunction of the phenylalanine hydroxylase (PAH) enzyme, which is responsible for converting phenylalanine into tyrosine.

The primary types of phenylketonuria (PKU) include hyperphenylalaninemia (HPA), mild PKU, moderate and variant PKU, and classic PKU. Hyperphenylalaninemia (HPA) is a genetic metabolic disorder caused by a deficiency of phenylalanine hydroxylase, leading to elevated levels of phenylalanine in the blood. Treatment options for PKU consist of enzyme replacement therapy, gene therapy, medication, and dietary therapy. Diagnosis methods include genetic testing, biochemical testing, and newborn screening. The key end users of PKU treatments and diagnostics include specialty clinics, research institutes, home healthcare providers, and hospitals.

The phenylketonuria (PKU) market research report is one of a series of new reports from The Business Research Company that provides phenylketonuria (PKU) market statistics, including the phenylketonuria (PKU) industry global market size, regional shares, competitors with the phenylketonuria (PKU) market share, detailed phenylketonuria (PKU) market segments, market trends, and opportunities, and any further data you may need to thrive in the phenylketonuria (PKU) industry. This phenylketonuria (PKU) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The phenylketonuria (PKU) market size has grown strongly in recent years. It will grow from $0.85 billion in 2024 to $0.93 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to the expansion of newborn screening programs, increasing awareness of metabolic disorders, advancements in PKU dietary management, the growing availability of medical foods, and regulatory approvals for PKU treatments.

The phenylketonuria (PKU) market size is expected to see strong growth in the next few years. It will grow to $1.30 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to the increasing adoption of gene therapy, the expansion of enzyme replacement therapies, rising investments in rare disease research, growing demand for personalized medicine, and government support for PKU treatment coverage. Major trends include the development of RNA-based therapies, the rise of digital health solutions for PKU management, increased collaborations between biotech firms and research institutions, a focus on non-dietary treatment alternatives, and the expansion of telehealth services for PKU patients.

The rising incidence of genetic disorders is expected to drive the growth of the phenylketonuria (PKU) market in the coming years. Genetic disorders are medical conditions caused by abnormalities in an individual's DNA, including mutations, deletions, or duplications of genes or chromosomes. The increasing prevalence of these disorders can be attributed to factors such as rising maternal age, environmental influences, advancements in diagnostic technologies, and greater awareness, leading to improved detection rates. Phenylketonuria plays a key role in understanding genetic disorders by illustrating how inherited enzyme deficiencies can result in severe metabolic complications. For example, in March 2024, Gene People, a UK-based registered charity, reported that genetic conditions affect approximately 1 in 25 children, impacting over 2.4 million children and adults in the UK. Additionally, around 30,000 newborns and children in the UK are diagnosed with a genetic condition each year. As a result, the increasing incidence of genetic disorders is fueling the expansion of the phenylketonuria (PKU) market.

Leading companies in the phenylketonuria (PKU) market are focusing on technological advancements to enhance the efficacy and safety of PKU treatments. One such innovation is the use of physiomimic technology, which replicates human physiological conditions to improve drug absorption and metabolism. Physiomimic technology comprises a set of hardware, consumables, and assay protocols designed to simulate complex human biology and precisely predict human drug responses. For instance, in October 2022, Relief Therapeutics Holding SA, a Switzerland-based biopharmaceutical company, announced the launch of PKU Golike. This next-generation medical food product, developed using patented pharmaceutical-grade physiomimic technology, is designed for the dietary management of phenylketonuria (PKU). PKU Golike is a prolonged-release amino acid product available in granules, packets, and medical food bars. Its unique coating enables the physiological absorption of amino acids similar to natural proteins while masking their unpleasant taste, odor, and aftertaste.

In August 2024, Otsuka Holdings Co. Ltd., a Japan-based pharmaceutical company, acquired Jnana Therapeutics Inc. for approximately $1.1 billion. Through this acquisition, Otsuka Pharmaceutical gains access to JNT-517, an oral drug for treating the rare genetic disorder phenylketonuria (PKU), while also strengthening its pipeline of innovative therapies for autoimmune diseases. Jnana Therapeutics Inc. is a US-based biotechnology company specializing in the treatment of phenylketonuria (PKU).

Major players in the phenylketonuria (pku) market are Abbott Laboratories, Merck KGaA, Agios Pharmaceuticals Inc., BioMarin Pharmaceutical Inc., PTC Therapeutics Inc., Ultragenyx Pharmaceutical Inc., Nutricia International Private Limited, Codexis Inc., Eton Pharmaceuticals Inc., Vitaflo International Ltd., American Gene Technologies International Inc., Cambrooke Therapeutics Inc., Generation Bio Co., Mead Johnson & Company, LLC, Relief Therapeutics Holding SA, SOM Innovation Biotech S.A., Synlogic Inc., Galen Ltd, Aptatek Biosciences Inc., Homology Medicines Inc.

North America was the largest region in the phenylketonuria (PKU) market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in phenylketonuria (PKU) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the phenylketonuria (PKU) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The phenylketonuria (PKU) market consists of revenues earned by entities by provide services such as enzyme therapy, screening tests, PKU tests, and PKU formula. The market value includes the value of related goods sold by the service provider or included within the service offering. The phenylketonuria (PKU) market also includes sales of sapropterin (Kuvan), pegvaliase-pqpz (Palynziq) and dietary supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Phenylketonuria (PKU) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on phenylketonuria (pku) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for phenylketonuria (pku) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The phenylketonuria (pku) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Hyperphenylalaninemia; Mild Phenylketonuria (PKU); Moderate And Variant; Classic Phenylketonuria (PKU)
2) By Treatment Type: Enzyme Replacement Therapy; Gene Therapy; Medication; Dietary Therapy
3) By Diagnosis: Genetic Testing; Biochemical Testing; Newborn Screening
4) By End-User: Specialty Clinics; Research Institutes; Home Healthcare; Hospitals
Subsegments:
1) By Hyperphenylalaninemia: Mild Hyperphenylalaninemia; Moderate Hyperphenylalaninemia; Severe Hyperphenylalaninemia
2) By Mild Phenylketonuria (PKU): Mild PKU with dietary management; Mild PKU with enzyme supplementation
3) By Moderate And Variant: Moderate PKU with medication; Variant PKU with treatment variations
4) By Classic Phenylketonuria (PKU): Classic PKU with strict dietary management; Classic PKU with enzyme replacement therapy
Companies Mentioned:Abbott Laboratories; Merck KGaA; Agios Pharmaceuticals Inc.; BioMarin Pharmaceutical Inc.; PTC Therapeutics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r34123

1. Executive Summary

2. Phenylketonuria (PKU) Market Characteristics

3. Phenylketonuria (PKU) Market Trends And Strategies

4. Phenylketonuria (PKU) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Phenylketonuria (PKU) Growth Analysis And Strategic Analysis Framework

5.1. Global Phenylketonuria (PKU) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Phenylketonuria (PKU) Market Growth Rate Analysis
5.4. Global Phenylketonuria (PKU) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Phenylketonuria (PKU) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Phenylketonuria (PKU) Total Addressable Market (TAM)

6. Phenylketonuria (PKU) Market Segmentation

6.1. Global Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hyperphenylalaninemia
Mild Phenylketonuria (PKU)
Moderate And Variant
Classic Phenylketonuria (PKU)
6.2. Global Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzyme Replacement Therapy
Gene Therapy
Medication
Dietary Therapy
6.3. Global Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Testing
Biochemical Testing
Newborn Screening
6.4. Global Phenylketonuria (PKU) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Specialty Clinics
Research Institutes
Home Healthcare
Hospitals
6.5. Global Phenylketonuria (PKU) Market, Sub-Segmentation Of Hyperphenylalaninemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mild Hyperphenylalaninemia
Moderate Hyperphenylalaninemia
Severe Hyperphenylalaninemia
6.6. Global Phenylketonuria (PKU) Market, Sub-Segmentation Of Mild Phenylketonuria (PKU), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mild PKU with dietary management
Mild PKU with enzyme supplementation
6.7. Global Phenylketonuria (PKU) Market, Sub-Segmentation Of Moderate And Variant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Moderate PKU with medication
Variant PKU with treatment variations
6.8. Global Phenylketonuria (PKU) Market, Sub-Segmentation Of Classic Phenylketonuria (PKU), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Classic PKU with strict dietary management
Classic PKU with enzyme replacement therapy

7. Phenylketonuria (PKU) Market Regional And Country Analysis

7.1. Global Phenylketonuria (PKU) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Phenylketonuria (PKU) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Phenylketonuria (PKU) Market

8.1. Asia-Pacific Phenylketonuria (PKU) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Phenylketonuria (PKU) Market

9.1. China Phenylketonuria (PKU) Market Overview
9.2. China Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Phenylketonuria (PKU) Market

10.1. India Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Phenylketonuria (PKU) Market

11.1. Japan Phenylketonuria (PKU) Market Overview
11.2. Japan Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Phenylketonuria (PKU) Market

12.1. Australia Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Phenylketonuria (PKU) Market

13.1. Indonesia Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Phenylketonuria (PKU) Market

14.1. South Korea Phenylketonuria (PKU) Market Overview
14.2. South Korea Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Phenylketonuria (PKU) Market

15.1. Western Europe Phenylketonuria (PKU) Market Overview
15.2. Western Europe Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Phenylketonuria (PKU) Market

16.1. UK Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Phenylketonuria (PKU) Market

17.1. Germany Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Phenylketonuria (PKU) Market

18.1. France Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Phenylketonuria (PKU) Market

19.1. Italy Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Phenylketonuria (PKU) Market

20.1. Spain Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Phenylketonuria (PKU) Market

21.1. Eastern Europe Phenylketonuria (PKU) Market Overview
21.2. Eastern Europe Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Phenylketonuria (PKU) Market

22.1. Russia Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Phenylketonuria (PKU) Market

23.1. North America Phenylketonuria (PKU) Market Overview
23.2. North America Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Phenylketonuria (PKU) Market

24.1. USA Phenylketonuria (PKU) Market Overview
24.2. USA Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Phenylketonuria (PKU) Market

25.1. Canada Phenylketonuria (PKU) Market Overview
25.2. Canada Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Phenylketonuria (PKU) Market

26.1. South America Phenylketonuria (PKU) Market Overview
26.2. South America Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Phenylketonuria (PKU) Market

27.1. Brazil Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Phenylketonuria (PKU) Market

28.1. Middle East Phenylketonuria (PKU) Market Overview
28.2. Middle East Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Phenylketonuria (PKU) Market

29.1. Africa Phenylketonuria (PKU) Market Overview
29.2. Africa Phenylketonuria (PKU) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Phenylketonuria (PKU) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Phenylketonuria (PKU) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Phenylketonuria (PKU) Market Competitive Landscape And Company Profiles

30.1. Phenylketonuria (PKU) Market Competitive Landscape
30.2. Phenylketonuria (PKU) Market Company Profiles
- 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Agios Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. BioMarin Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. PTC Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Phenylketonuria (PKU) Market Other Major And Innovative Companies

31.1. Ultragenyx Pharmaceutical Inc.
31.2. Nutricia International Private Limited
31.3. Codexis Inc.
31.4. Eton Pharmaceuticals Inc.
31.5. Vitaflo International Ltd.
31.6. American Gene Technologies International Inc.
31.7. Cambrooke Therapeutics Inc.
31.8. Generation Bio Co.
31.9. Mead Johnson & Company, LLC
31.10. Relief Therapeutics Holding SA
31.11. SOM Innovation Biotech S.A.
31.12. Synlogic Inc.
31.13. Galen Ltd
31.14. Aptatek Biosciences Inc.
31.15. Homology Medicines Inc.

32. Global Phenylketonuria (PKU) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Phenylketonuria (PKU) Market

34. Recent Developments In The Phenylketonuria (PKU) Market

35. Phenylketonuria (PKU) Market High Potential Countries, Segments and Strategies

35.1 Phenylketonuria (PKU) Market In 2029 - Countries Offering Most New Opportunities
35.2 Phenylketonuria (PKU) Market In 2029 - Segments Offering Most New Opportunities
35.3 Phenylketonuria (PKU) Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer